You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for Plaintiff(s) v. Defendant(s) (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Plaintiff(s) v. Defendant(s) (D. Del. 2020)

Docket ⤷  Sign Up Date Filed 2019-01-01
Court District Court, D. Delaware Date Terminated
Cause 99:9999 (Miscellaneous Case - Cause Not Known) Assigned To
Jury Demand None Referred To
Parties DEFENDANT(S); PLAINTIFF(S)
Patents 10,004,717; 10,010,507; 10,039,745; 10,052,267; 10,106,548; 10,124,000; 10,125,140; 10,143,723; 10,143,792; 10,154,987; 10,172,808; 10,188,632; 10,206,939; 10,258,637; 10,307,419; 10,376,487; 10,407,434; 10,426,780; 10,478,453; 10,543,192; 10,548,875; 10,583,155; 10,617,698; 6,024,981; 6,126,971; 6,200,604; 6,328,994; 6,403,120; 6,419,958; 6,500,814; 6,696,481; 6,794,410; 6,965,027; 7,105,486; 7,223,735; 7,229,636; 7,265,221; 7,301,023; 7,314,938; 7,404,489; 7,442,830; 7,514,444; 7,638,552; 7,655,630; 7,659,253; 7,659,254; 7,662,787; 7,662,788; 7,671,030; 7,671,031; 7,674,774; 7,678,770; 7,678,771; 7,687,466; 7,687,467; 7,691,411; 7,700,561; 7,713,936; 7,713,938; 7,718,619; 7,723,305; 7,723,390; 7,741,356; 7,745,460; 7,790,743; 7,816,396; 7,842,699; 7,846,961; 7,879,349; 7,888,362; 7,928,122; 8,003,353; 8,008,309; 8,039,009; 8,084,047; 8,084,475; 8,133,893; 8,147,866; 8,158,616; 8,168,655; 8,338,489; 8,349,840; 8,367,701; 8,399,514; 8,420,629; 8,476,284; 8,497,277; 8,551,957; 8,592,450; 8,618,109; 8,618,160; 8,697,711; 8,735,403; 8,754,090; 8,754,091; 8,859,504; 8,859,610; 8,877,938; 8,927,574; 8,940,714; 8,952,015; 8,957,079; 8,987,262; 9,073,933; 9,079,949; 9,085,553; 9,089,587; 9,161,926; 9,175,017; 9,181,257; 9,186,346; 9,216,174; 9,233,117; 9,233,118; 9,242,986; 9,259,414; 9,296,753; 9,353,088; 9,388,134; 9,415,007; 9,447,077; 9,517,219; 9,522,919; 9,527,833; 9,655,843; 9,655,857; 9,669,008; 9,675,587; 9,725,455; 9,744,105; 9,763,933; 9,775,808; 9,808,442; 9,839,637; 9,889,144; 9,890,141; 9,901,539; 9,937,181; 9,957,232; RE36,247; RE41,783; RE46,284
Attorneys Plaintiff(s)
Firms Dickie McCamey & Chilcote, P.C.
Link to Docket External link to docket
Biologic Drugs cited in Plaintiff(s) v. Defendant(s)

The biologic drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for Plaintiff(s) v. Defendant(s) (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2020-09-25 1071 Complaint ,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). {01611126;v1 } …the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of U.S. Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 18. The United States Patent and Trademark Office ( External link to document
2020-09-25 1072 Complaint 9,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). 33. In response to Lupin…the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of U.S. Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 25. The United States Patent and Trademark Office ( External link to document
2020-09-25 1073 Complaint 9,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). {01611225;v1 } …the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 36. The United States Patent and Trademark Office ( External link to document
2020-10-07 1131 Complaint United States Patent Nos. 10,617,698 (“the ’698 Patent”), 10,660,908 (“the ’908 Patent”), 10,682,36410,682,364 (“the ’364 Patent”), 10,688,108 (“the ’108 Patent”), and 10,716,799 (“the ’799 Patent”) (collectively… This is a civil action for patent infringement arising under the patent laws of the United States, … This is a civil action for patent infringement arising under the patent laws of the United States, …are covered by claims of the Patents-in-Suit. 22. The Patents-in-Suit are listed in Approved External link to document
2020-10-08 1133 Complaint 9,763,886 (“the ‘886 patent”); 9,073,933 (“the ’933 patent”); 9,522,919 (“the ’919 patent”); and 10,407,434…RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 9,073,933) 58. Purdue…United States Patent Nos. 9,763,933 (“the Mannion ’933 patent”); 9,775,808 (“the ’808 patent”); 9,763,886…infringed the ’886 patent. Defendants have infringed the Orange Book patents and the ’886 patent at least under…1. This is an action for patent infringement arising under the patent laws of the United States, External link to document
2020-10-09 1140 Complaint Pharmaceuticals Limited’s Dapsone Gel, 7.5%; U.S. Patent Nos. 9,161,926 and 9,517,219” (the “Notice Letter”). …This is an action for patent infringement brought under the United States Patent Act and the Hatch-Waxman…the expiration of United States Patent No. 9,517,219 (“the ’219 Patent”), which covers, inter alia, the… THE PATENT-IN-SUIT 16. On December 13, 2016, the United States Patent and Trademark…before the ʼ219 Patent expires. CLAIM FOR INFRINGEMENT OF THE ’219 PATENT 28. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.